GlycoMimetics is an oncology-focused biotechnology company. We are dedicated to improving the lives of patients by discovering, developing and commercializing novel, small-molecule glycomimetic product candidates. Our management team consists of industry leaders with deep experience in the pharmaceutical/biotech industry. Since our inception, we have developed a diversified product pipeline. Today, the company’s proprietary ...
GlycoMimetics is an oncology-focused biotechnology company. We are dedicated to improving the lives of patients by discovering, developing and commercializing novel, small-molecule glycomimetic product candidates. Our management team consists of industry leaders with deep experience in the pharmaceutical/biotech industry. Since our inception, we have developed a diversified product pipeline. Today, the company’s proprietary investigational drug for acute myeloid leukemia (AML) is being evaluated in two pivotal Phase 3 clinical trials.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.